451 related articles for article (PubMed ID: 17464987)
1. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.
Rahman SM; Schroeder-Gloeckler JM; Janssen RC; Jiang H; Qadri I; Maclean KN; Friedman JE
Hepatology; 2007 May; 45(5):1108-17. PubMed ID: 17464987
[TBL] [Abstract][Full Text] [Related]
2. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
[TBL] [Abstract][Full Text] [Related]
3. Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo.
Shen B; Yu J; Wang S; Chu ES; Wong VW; Zhou X; Lin G; Sung JJ; Chan HL
Hepatology; 2008 Feb; 47(2):473-83. PubMed ID: 18157836
[TBL] [Abstract][Full Text] [Related]
4. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
[TBL] [Abstract][Full Text] [Related]
5. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
Yu J; Ip E; Dela Peña A; Hou JY; Sesha J; Pera N; Hall P; Kirsch R; Leclercq I; Farrell GC
Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
[TBL] [Abstract][Full Text] [Related]
7. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis.
Dela Peña A; Leclercq I; Field J; George J; Jones B; Farrell G
Gastroenterology; 2005 Nov; 129(5):1663-74. PubMed ID: 16285964
[TBL] [Abstract][Full Text] [Related]
9. JNK1 but not JNK2 promotes the development of steatohepatitis in mice.
Schattenberg JM; Singh R; Wang Y; Lefkowitch JH; Rigoli RM; Scherer PE; Czaja MJ
Hepatology; 2006 Jan; 43(1):163-72. PubMed ID: 16374858
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis.
Csak T; Bala S; Lippai D; Kodys K; Catalano D; Iracheta-Vellve A; Szabo G
PLoS One; 2015; 10(6):e0129251. PubMed ID: 26042593
[TBL] [Abstract][Full Text] [Related]
11. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.
Ip E; Farrell GC; Robertson G; Hall P; Kirsch R; Leclercq I
Hepatology; 2003 Jul; 38(1):123-32. PubMed ID: 12829994
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
[TBL] [Abstract][Full Text] [Related]
13. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis.
dela Peña A; Leclercq IA; Williams J; Farrell GC
J Hepatol; 2007 Feb; 46(2):304-13. PubMed ID: 17157947
[TBL] [Abstract][Full Text] [Related]
14. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
Leclercq IA; Farrell GC; Sempoux C; dela Peña A; Horsmans Y
J Hepatol; 2004 Dec; 41(6):926-34. PubMed ID: 15582125
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
16. Steatohepatitis develops rapidly in transgenic mice overexpressing Abcb11 and fed a methionine-choline-deficient diet.
Sundaram SS; Whitington PF; Green RM
Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1321-7. PubMed ID: 15650132
[TBL] [Abstract][Full Text] [Related]
17. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
Sugino H; Kumagai N; Watanabe S; Toda K; Takeuchi O; Tsunematsu S; Morinaga S; Tsuchimoto K
J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte-specific deletion of Brg1 alleviates methionine-and-choline-deficient diet (MCD) induced non-alcoholic steatohepatitis in mice.
Kong M; Chen X; Xu H; Wenping ; Fang M; Xu Y
Biochem Biophys Res Commun; 2018 Sep; 503(1):344-351. PubMed ID: 29890136
[TBL] [Abstract][Full Text] [Related]
19. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
Larter CZ; Yeh MM; Williams J; Bell-Anderson KS; Farrell GC
J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
[TBL] [Abstract][Full Text] [Related]
20. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease.
Puri P; Mirshahi F; Cheung O; Natarajan R; Maher JW; Kellum JM; Sanyal AJ
Gastroenterology; 2008 Feb; 134(2):568-76. PubMed ID: 18082745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
